Promoter Polymorphism of RGS2 Gene Is Associated with Change of Blood Pressure in Subjects with Antihypertensive Treatment: The Azelnidipine and Temocapril in Hypertensive Patients with Type 2 Diabetes Study

We performed a prospective study to examine the genetic effect on the response to a calcium (Ca) channel blocker, azelnidipine and an ACE inhibitor, temocapril treatment in patients with hypertension, as a part of the prior clinical trial, the Azelnidipine and Temocapril in Hypertensive Patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugimoto, Ken, Katsuya, Tomohiro, Kamide, Kei, Fujisawa, Tomomi, Shimaoka, Izumi, Ohishi, Mitsuru, Morishita, Ryuichi, Ogihara, Toshio, Rakugi, Hiromi
Formato: Texto
Lenguaje:English
Publicado: SAGE-Hindawi Access to Research 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958339/
https://www.ncbi.nlm.nih.gov/pubmed/20981351
http://dx.doi.org/10.4061/2010/196307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958339/
https://www.ncbi.nlm.nih.gov/pubmed/20981351
http://dx.doi.org/10.4061/2010/196307

Ejemplares similares